Home | By sponsor

CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title Date of Registration State
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection 2012-10-12 Registered
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series 2012-09-12 Registered
HeberPAG® in Mycosis Fungoides (MYFIC Study) 2012-06-08 Registered
THERESA-4 Study 2011-10-25 Registered
Teravac HIV in chronic HIV-1. 2011-08-10 Registered
MAGINC Study 2011-07-12 Registered
INJURE Study 2011-07-11 Registered
SOFIA Study 2011-05-24 Registered
HeberproGen Study 2011-05-20 Registered
InMuMyel I Study 2011-05-19 Registered
Gamma IFN in Idiopathic Pulmonary Fibrosis. 2011-05-17 Registered
CERVISEG-300-I Study 2011-05-17 Registered
Clinical Trial Heberbiovac HB vaccine Material Reference Batch 2011-05-16 Registered
NASVAC therapeutic vaccine study 2011-05-16 Registered
Heberprovac Study 2011-05-16 Registered
TS-FARMEV Study 2011-05-16 Registered
GrUVen-I Study 2011-05-03 Registered
EGFpeeling I 2011-05-03 Registered
NEUVITAL V Study 2011-04-30 Registered
Change in Manufacture Process of Heberbiovac HB vaccine. 2011-04-30 Registered